Z-2956-2020 Class II Terminated
FDA device recall Z-2956-2020 was initiated by Novarad Corporation on September 10, 2019 and is designated Class II. Reason for recall: The firm received a report of an atypical dataset being generated. When using the cross-localization feature and images from a modality that generates asymmetrical images, the cross-localization refer… The recall status is terminated (terminated June 30, 2021). Affected quantity: 197 units.
Recall Details
- Product Type
- Devices
- Report Date
- September 23, 2020
- Initiation Date
- September 10, 2019
- Termination Date
- June 30, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 197 units
Product Description
Reason for Recall
Distribution Pattern
Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AZ, CA, CO, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The countries of Canada, Colombia, Dominican Republic, Indonesia, Jordan, Mexico, Peru, Phillipines, and United Kingdom.